NRX Pharmaceuticals, Inc. (NRXP): Insider Trading, Congress Trades & Research | Tormere

NRXP

$2.49+11.16%visit website

NRX Pharmaceuticals, Inc.

Market Cap

$108M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

2.06

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

31.8

TTM to Jun 2026 · revenue

Flagged input, hover for details

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2024 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	242	983	1,068	1,101	3,394
Cost of revenue	97	408	631	675	1,811
Research & development	1,429	558	1,309	2,116	5,412
Selling, general & administrative	2,808	4,569	3,813	4,745	15,935
Operating income	(4,024)	(4,624)	(4,742)	(6,505)	(19,895)
Interest expense	0	671	233	240	1,144
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(5,890)	360	(1,430)	(16,520)	(23,480)
EPS (basic) ($)	(0.27)		(0.04)	(0.44)	—
Weighted avg. shares (basic)	22,231		32,325	37,649

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 31 more quarters, back to Q4 FY2017, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga · 2026-11-02

Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

Benzinga · 2026-11-02

NRXP Stock Dips As Traders Weigh Steep Losses And Cash Runway

StocksToTrade · 2026-11-01

NRXP Stock Pulls Back As Traders Weigh Deep Losses

Timothy Sykes · 2026-11-01

NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Ketamine Injection

Yahoo · 2026-10-30

NRXP: FDA approves preservative-free ketamine as launch inventory builds for a shortage-hit market

TradingView · 2026-10-30

NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA Approval of Preservative-Free Ketamine Transcript

SeekingAlpha · 2026-10-30

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Yahoo · 2026-10-30

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-30

NRx Pharmaceuticals Receives FDA Approval Of Its Abbreviated New Drug Application For Preservative-Free Ketamine

Benzinga · 2026-10-30

Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-30

NRx Pharmaceuticals (NRXP) Stock Jumps Over 26% After Hours: What's Behind the Surge?

Benzinga · 2026-10-30

NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine

Yahoo · 2026-10-29

Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates

Yahoo · 2026-10-29

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Yahoo · 2026-10-19

Informational purposes only, not investment advice.